- Home
- LIQT vs BOLT Comparison
LIQT vs BOLT Comparison
Compare LIQT & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIQT
- BOLT
- Stock Information
- Founded
- LIQT 2004
- BOLT 2015
- Country
- LIQT Denmark
- BOLT United States
- Employees
- LIQT N/A
- BOLT N/A
- Industry
- LIQT Industrial Machinery/Components
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- LIQT Technology
- BOLT Health Care
- Exchange
- LIQT Nasdaq
- BOLT Nasdaq
- Market Cap
- LIQT 16.1M
- BOLT 16.8M
- IPO Year
- LIQT N/A
- BOLT 2021
- Fundamental
- Price
- LIQT $1.80
- BOLT $6.19
- Analyst Decision
- LIQT Strong Buy
- BOLT Buy
- Analyst Count
- LIQT 2
- BOLT 3
- Target Price
- LIQT $4.80
- BOLT $50.00
- AVG Volume (30 Days)
- LIQT 30.9K
- BOLT 18.9K
- Earning Date
- LIQT 08-13-2025
- BOLT 08-12-2025
- Dividend Yield
- LIQT N/A
- BOLT N/A
- EPS Growth
- LIQT N/A
- BOLT N/A
- EPS
- LIQT N/A
- BOLT N/A
- Revenue
- LIQT $14,986,815.00
- BOLT $3,638,000.00
- Revenue This Year
- LIQT $36.89
- BOLT N/A
- Revenue Next Year
- LIQT $16.33
- BOLT $24.14
- P/E Ratio
- LIQT N/A
- BOLT N/A
- Revenue Growth
- LIQT N/A
- BOLT N/A
- 52 Week Low
- LIQT $1.34
- BOLT $5.20
- 52 Week High
- LIQT $3.20
- BOLT $15.60
- Technical
- Relative Strength Index (RSI)
- LIQT 62.68
- BOLT 52.70
- Support Level
- LIQT $1.74
- BOLT $5.68
- Resistance Level
- LIQT $1.84
- BOLT $6.40
- Average True Range (ATR)
- LIQT 0.12
- BOLT 0.30
- MACD
- LIQT 0.03
- BOLT 0.09
- Stochastic Oscillator
- LIQT 81.47
- BOLT 79.81
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.